BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36371204)

  • 1. MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway.
    Cai K; Deng L; Zheng D; Li L; He Z; Yu C
    J Transl Med; 2022 Nov; 20(1):528. PubMed ID: 36371204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1/β-catenin signaling pathway.
    Gu H; Li Y; Cui X; Cao H; Hou Z; Ti Y; Liu D; Gao J; Wang Y; Wen P
    Biochem Pharmacol; 2022 Jan; 195():114870. PubMed ID: 34902339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
    J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling.
    Li TH; Zhao BB; Qin C; Wang YY; Li ZR; Cao HT; Yang XY; Zhou XT; Wang WB
    Cell Oncol (Dordr); 2021 Dec; 44(6):1425-1437. PubMed ID: 34791638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis.
    Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
    Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.
    Li Q; Wang G; Tao J; Chen W
    Pathol Res Pract; 2021 Sep; 225():153545. PubMed ID: 34352441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00491 Facilitates Tumor Progression of Lung Adenocarcinoma via Wnt/β-Catenin-Signaling Pathway by Regulating MTSS1 Ubiquitination.
    Wan H; Lin T; Shan M; Lu J; Guo Z
    Cells; 2022 Nov; 11(23):. PubMed ID: 36496997
    [No Abstract]   [Full Text] [Related]  

  • 12. Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β.
    Chen LJ; Wu L; Wang W; Zhai LL; Xiang F; Li WB; Tang ZG
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 35929518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
    J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STMN2 overexpression promotes cell proliferation and EMT in pancreatic cancer mediated by WNT/β-catenin signaling.
    Shao M; Wang L; Zhang Q; Wang T; Wang S
    Cancer Gene Ther; 2023 Mar; 30(3):472-480. PubMed ID: 36460804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
    Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
    World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
    Han L; Zan Y; Huang C; Zhang S
    Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
    Zhao J; Wang Y; Han M; Lu H; Chen X; Liu S; Yuan X; Han K; Liang P; Cheng J
    Cancer Sci; 2020 Mar; 111(3):994-1007. PubMed ID: 31746531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.